Home / Private raises / LISATA THERAPEUTICS, INC.
LISATA THERAPEUTICS, INC.
Biotechnology · Basking Ridge, New Jersey · $352M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-10-02 | D (new) | $352M | $352M | 20 | 506(b) | Equity, Security to be acquired | Sep 17 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Sold through (placement agents)
| Broker-dealer | Solicited in |
|---|---|
| H.C.WAINWRIGHT & CO., LLC | All States |
| LEERINK PARTNERS LLC | All States |
| LIFESCI CAPITAL | All States |
Sales commissions $2.6M in the latest filing.
Issuer
| Industry | Biotechnology |
| Located | Basking Ridge, New Jersey |
| Entity | Corporation |
| Incorporated | Delaware |
| SEC CIK | 320017 |
People named in the latest filing
| Name | Role |
|---|---|
| DAVID MAZZO | Executive Officer, Director |
| JAMES NISCO | Executive Officer |
| TARIQ IMAM | Executive Officer |
| GREGORY BROWN | Director |
| HEIDI HENSON | Director |
| CYNTHIA FLOWERS | Director |
| STEVEN KLOSK | Director |
| MOHAMMAD AZAB | Director |
| TED LOVE | Director |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
